Procter & Gamble Stock: A Buy Opportunity Before Q2 Earnings?

In This Article:

The Procter & Gamble Company PG, also known as P&G, is set to report second-quarter fiscal 2025 results on Jan. 22, before the opening bell. The company is expected to have witnessed year-over-year sales and earnings growth in the to-be-reported quarter.

Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.

The Zacks Consensus Estimate for fiscal second-quarter revenues is pegged at $21.7 billion, suggesting a 1.1% rise from the prior-year quarter’s reported figure. The consensus mark for PG’s fiscal second-quarter earnings is pegged at $1.87 per share, indicating 1.6% growth from the year-ago quarter’s actual. The consensus mark has moved down by a penny in the past 30 days.

The Cincinnati, OH-based company has consistently delivered steady earnings, evidenced by its bottom-line beat trend over the past nine quarters. PG has a trailing four-quarter earnings surprise of 4.8%, on average, including a 1.6% surprise in the most recent quarter. With this record, the question is whether PG can sustain this momentum.

PG’s Earnings Whispers

Our proven model does not conclusively predict an earnings beat for Procter & Gamble this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that is not the case here. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Procter & Gamble has a Zacks Rank #3 and an Earnings ESP of -1.42%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Key Trends to Watch Ahead of PG's Q2 Earnings

Procter & Gamble has been demonstrating its dominance in the global market by leveraging its brand strength to drive organic sales growth. As a manufacturer of products catering to the daily needs of consumers worldwide, P&G's success in the preceding quarters can be attributed to its robust brand portfolio and effective business strategies. The persistence of these trends is expected to benefit the company’s organic sales for the fiscal second quarter.

PG’s organic sales for the fiscal second quarter are anticipated to have benefited from strong pricing strategies, a favorable product mix and robust segmental performances.

Our model predicts year-over-year organic sales growth of 2% for P&G in the second quarter of fiscal 2025. Fiscal second-quarter organic sales are expected to rise 5% each for the Grooming and Health Care segments, and 3% for Fabric & Home Care segment, offset by a 1% decline for the Beauty segment. Organic sales for the Baby, Feminine & Family Care segment is expected to be flat year over year in the fiscal second quarter.

P&G has been pursuing cost-saving and productivity measures to drive margins and reinforce its competitive advantage. The company's commitment to enhancing productivity while mitigating macro cost headwinds has been integral in maintaining balanced top and bottom-line growth. Its focus on productivity and cost-saving plans are likely to have boosted margins in the to-be-reported quarter.

We expect PG's core gross margin for the fiscal second quarter to have been influenced by significant productivity savings. Our model predicts a year-over-year core gross margin expansion of 10 bps for the to-be-reported quarter.